← Open Payments lookup

CEDRIC WILLIS: Open Payments

NPI 1801196589 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,488 in 124 payments from 20 companies in 2025. Trend: 2023 $3,194 · 2024 $3,030 · 2025 $2,488

Food & beverage: $2,400Education: $87
CompanyPaymentsAmount
ABBVIE INC.39$692
Janssen Biotech, Inc.15$326
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$282
Phathom Pharmaceuticals, Inc.9$186
QOL Medical, LLC9$183
GENZYME CORPORATION6$163
Aimmune Therapeutics, Inc.5$124
Lilly USA, LLC5$104
Intercept Pharmaceuticals, Inc.4$82
Ipsen Biopharmaceuticals, Inc3$66

Products named: TREMFYA, LINZESS, XIFAXAN, VOQUEZNA, Sucraid, SKYRIZI, DUPIXENT, CREON.

Industry payments across LA — which companies pay providers there.